Kevin Mcculloch

President and Chief Operating Officer · 2 filings · Latest: Mar 12, 2026

Xeris Biopharma Holdings, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
XERS	Kevin Mcculloch	President and Chief Operating Officer	Mar 12, 2026	Option Exercise	$4.09	48,898	$200.0K	1,777,725	Mar 16 10:11 PM
XERS	KEVIN MCCULLOCH	—	Jan 8, 2026	Proposed Sale	$7.21	60,000	$432.6K	—	Jan 8 9:22 PM